The hypothalamic-pituitary-gonadal axis governs nearly every reproductive hormone. Peptide protocols that restore upstream signaling produce downstream hormonal balance without the bluntness of traditional hormone replacement.
Reproductive hormones don't operate independently. They cascade from the hypothalamus down. Disruption at any point ripples through the entire system. Peptide interventions target the upstream regulators — restoring natural pulsatility rather than applying static replacement doses.
The upstream regulator of the entire HPG axis. Kisspeptin neurons in the hypothalamus control the pulsatile release of GnRH — without which the pituitary cannot produce LH or FSH, and without which the ovaries cannot produce estradiol or progesterone in appropriate quantities.
Loss of kisspeptin signaling is now recognized as a primary driver of hypothalamic amenorrhea, polycystic ovary syndrome (PCOS) pathophysiology, and stress-induced reproductive suppression. Restoring kisspeptin tone addresses the root cause rather than managing downstream symptoms.
CJC-1295 is a growth hormone-releasing hormone (GHRH) analog that extends the half-life of endogenous GHRH. Ipamorelin is a selective growth hormone secretagogue that mimics ghrelin without the cortisol, aldosterone, or prolactin stimulation of older compounds. Together, they produce a physiologic pulsatile GH release.
Growth hormone is a critical co-regulator of female reproductive function. IGF-1 (GH's downstream mediator) supports follicular development, luteal function, and endometrial receptivity. Women with poor ovarian response in IVF frequently show GH deficiency patterns. GH-optimizing peptide protocols represent an adjunct to reproductive hormone management.
A 43-amino acid peptide ubiquitous in virtually all human cells. TB-4 promotes cell migration, proliferation, and differentiation through actin sequestration and upregulation of angiogenesis pathways. Its anti-inflammatory effects extend to ovarian tissue, where chronic low-grade inflammation is increasingly recognized as a driver of premature ovarian insufficiency and poor egg quality.
In hormone balance protocols, TB-4 is used as an adjunct to reduce the inflammatory baseline that disrupts estrogen signaling and endometrial function, particularly in patients with endometriosis or chronic pelvic inflammatory history.
A synthetic analog of tuftsin with anxiolytic and nootropic properties. Selank modulates GABA-A receptor activity and reduces cortisol reactivity through effects on the HPA axis. The relevance to hormone balance is direct: chronic cortisol elevation suppresses GnRH pulsatility, reduces LH amplitude, and creates a functional hypoestrogenic state even in women with otherwise intact ovarian function.
Reducing the stress-cortisol burden is frequently the first step in restoring hormonal regularity in women with lifestyle-driven cycle disruption.
Share your goals, health history, and current medications through our secure intake form.
A board-certified provider reviews your history and conducts a telehealth consultation. Labs may be ordered.
If appropriate, a peptide protocol is prescribed — compounded at a licensed cGMP pharmacy.
Follow-up consultations, lab reviews, and protocol adjustments every step of the way.
Submit your intake and a licensed provider will reach out to schedule your consultation.
Request Consultation